Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Castration-Sensitive Prostate Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 0 results

Not applicableLooking for participantsNCT06652607
What this trial is testing

PSA Biochemical Response as Prognostic Factor in Metastatic Castration-Sensitive Prostate Cancer

Who this might be right for
Prostate CancerMetastatic CancerCastrate Sensitive Prostate Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 152
Not applicableLooking for participantsNCT04489719
What this trial is testing

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneMetastatic Prostate Carcinoma+1 more
University of Washington 48
Testing effectiveness (Phase 2)Ended earlyNCT03827473
What this trial is testing

Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer

Who this might be right for
Castration-Sensitive Prostate CarcinomaMetastatic Prostatic AdenocarcinomaStage IV Prostate Cancer+2 more
University of Utah 1
Early research (Phase 1)Looking for participantsNCT05818683
What this trial is testing

Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate NeoplasmsMetastatic Hormone-sensitive Prostate Cancer
Janssen Research & Development, LLC 300
Not applicableStudy completedNCT05701007
What this trial is testing

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Who this might be right for
Metastatic Castration Sensitive Prostate Cancer (mCSPC)Metastatic Castration Resistant Prostate Cancer (mCRPC)
Pfizer 1,083
Large-scale testing (Phase 3)Looking for participantsNCT06931340
What this trial is testing

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Who this might be right for
Castration-Sensitive Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Alliance for Clinical Trials in Oncology 1,260
Not applicableLooking for participantsNCT06835218
What this trial is testing

PROCARE - PROstate Cancer Real World Evidence Registry

Who this might be right for
Prostate CancerBiochemical Recurrence of Malignant Neoplasm of ProstateNon-metastatic Castration-resistant Prostate Cancer+2 more
UroTrials Company (GmbH) 5,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05717582
What this trial is testing

Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT Treatment

Who this might be right for
Metastatic Prostate CancerCastration-Sensitive Prostate Cancer
Fudan University 47
Large-scale testing (Phase 3)WithdrawnNCT05771896
What this trial is testing

Darolutamide With Radium-223 or Placebo and the Effect on Radiological Progression-Free Survival for Patients With mCSPC

Who this might be right for
Metastatic Prostate Cancer
GenesisCare USA
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07466498
What this trial is testing

Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial

Who this might be right for
Castration-Sensitive Prostate AdenocarcinomaMetastatic Castration-Sensitive Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Fred Hutchinson Cancer Center 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT07591467
What this trial is testing

Carboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate Cancer

Who this might be right for
BRCA-MutatedNeuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate CancerProstate Cancer
Gustave Roussy, Cancer Campus, Grand Paris 330
Testing effectiveness (Phase 2)Active Not RecruitingNCT05189457
What this trial is testing

First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer

Who this might be right for
Prostate CancerStage IV Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 32
Testing effectiveness (Phase 2)Looking for participantsNCT06654336
What this trial is testing

Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC)

Who this might be right for
Prostate AdenocarcinomaCastration Sensitive Prostate Cancer
Ontario Clinical Oncology Group (OCOG) 162
Large-scale testing (Phase 3)Active Not RecruitingNCT06120491
What this trial is testing

Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents

Who this might be right for
Metastatic Castration-Sensitive Prostate Cancer
AstraZeneca 1,898